For pharma, the bottle is part of the drug product’s quality system. This article sets out the supplier-side expectations — documentation, consistency and controlled environment — that procurement teams should build into their vendor qualify.
Bottles from our catalogue — bottle formats produced under documented GMP controls.
Documentation trail
Expect a material certificate, declaration of compliance and migration data, plus production records you can audit. Consistency batch to batch matters more than a one-off sample.
Controlled handling
Where the fill is sensitive, request cleanroom-compatible packing and controlled-environment handling. We discuss GMP-scope requirements per project rather than assume a single standard.
Change control
Resin lot, tooling and decoration changes should be communicated in advance so your stability and registration are not surprised. Build this into the supply agreement.
Supplier qualify
Treat the bottle like a component: audit the line, hold a technical file, and confirm Pharmaceutical & Medical Bottles specs in writing before first fill.
Compliance note: Chemical, medical and industrial fills need proven packaging. Shijin is ISO 9001:2015 certified and bottles are tested to ISTA transit standards for leak, drop and stack performance, with material and certification documents supplied on request.
Building the supplier file before first fill
A pharma vendor qualification rests on a documentation file, not a handshake. Collect the material certificate naming the resin grade, a declaration of compliance, migration data for the fill type, and production records you can audit. Keep these in a technical file so an audit — yours or a regulator’s — can be answered in minutes.
Batch-to-batch consistency matters more than a flawless first sample, because your stability and registration data assume the container does not change. A supplier who can show stable resin lots and tooling is worth more than one who impresses once.
Change control and controlled handling
- Require change control: any resin lot, tooling or decoration change must be communicated in advance, not discovered after a stability failure.
- Where the fill is sensitive, request cleanroom-compatible packing and controlled-environment handling.
- Write the spec into the supply agreement — neck finish, material grade, closure, and acceptance limits — before first fill.
- Treat the bottle as a component, auditing the line as you would a drug substance supplier.
These controls are what turn a container purchase into a documented part of the drug product’s quality system.
Related reading
- Pharmaceutical & Medical Bottles: Compliant Packaging for Healthcare
- Pill & Tablet Bottles: HDPE vs PET, Desiccant and CRC
- Medical Dropper Bottles: Dosing, Clarity and Closure
- Amber Bottles for Light-Sensitive Medicines & Supplements
What pharma formulas demand from the bottle
For pharma fills the bottle is part of the compliance and performance chain, not just a container. The body has to hold the formula without stress cracking or leaching, survive the filling line, and stay readable after months on a shelf or in a warehouse.
Across our 30+ blow-molding lines we see the same non-negotiables: a neck that seats the closure squarely, wall thickness tuned to the fill weight, and colour and decoration that survive transport and UV. A bottle that passes the bench test but fails the warehouse is not a pass.
If the formula is viscous, acidic or solvent-based, tell us at the enquiry stage. The resin choice and the lining of the closure both shift, and selecting them early is far cheaper than re-tooling after a failed stability test.
Capacities we stock for pharma
| Model | Material | Capacity | Neck |
|---|---|---|---|
| SJT0238 | PET | 238 ml | 28 mm |
| OEM/ODM 300ml HDPE Squeeze Bottle | HDPE | 300 ml | 28/410 |
| 500ml PE Cosmetic Bottle 28mm Neck | PE | 500 ml | 28 mm |
| SJT0079 | PET | 79 ml | 24 mm |
These are stock shapes from our catalogue — the same tools a buyer samples first before committing to a custom mold. Capacities run from small trial sizes to bulk drums, so most pharma programmes can start from an existing mold and skip tooling lead time.
Sampling from a stock mold also de-risks the launch: you get a real, fill-tested bottle in days, validate it on your line, then scale or customise once the volume is proven.
Compliance and documentation
Every food-contact and pharma-adjacent bottle we make is produced under ISO 9001 controls, with FDA, SGS and EU 10/2011 food-contact documentation available on request. For export we supply the material certificate and, where required, UN-marked HDPE options for chemical transport.
If your market needs a specific claim (BPA-free, documented recycled content, tamper-evident), tell us at the sampling stage so we select the right resin and closure before the first run.
Sampling and first-run support
Because the tool is cut in-house, sampling lead time is typically 3–10 days from drawing to first article. We hold the first-article sample against the drawing, confirm wall and weight, and only then move to bulk.
For a new programme that means you can prove the bottle on your filling line before committing to a large order — and repeats stay consistent because the same mold and resin are used on every run.
Frequently Asked Questions
What documents should a pharma bottle supplier provide?
Material certificate, declaration of compliance, migration data and production records you can audit.
Do you offer cleanroom packing?
We discuss cleanroom-compatible packing per project based on your GMP scope.
How are resin changes managed?
Lot, tooling and decoration changes should be communicated in advance under change control.
Is batch consistency guaranteed?
We control production per documented procedure; qualify us with a line audit and hold a technical file.
What documentation should a pharma bottle supplier provide?
A material certificate, declaration of compliance, migration data for your fill type, and auditable production records — kept together as your technical file.
Why is change control important for pharma bottles?
Because your stability and registration data assume the container stays the same. An unannounced resin or tooling change can invalidate that data, so changes must be communicated in advance.